Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Follow-up of patients with thyroglobulin-antibodies: Rising Tg-Ab trend is a risk factor for recurrence of differentiated thyroid cancer.

de Meer SGA, Vorselaars WMCM, Kist JW, Stokkel MPM, de Keizer B, Valk GD, Borel Rinkes IHM, Vriens MR.

Endocr Res. 2017 Nov;42(4):302-310. doi: 10.1080/07435800.2017.1319858. Epub 2017 May 16.

PMID:
28509618
2.

Selecting patients during the "learning curve" of endoscopic Totally Extraperitoneal (TEP) hernia repair.

Schouten N, Elshof JW, Simmermacher RK, van Dalen T, de Meer SG, Clevers GJ, Davids PH, Verleisdonk EJ, Westers P, Burgmans JP.

Hernia. 2013 Dec;17(6):737-43. doi: 10.1007/s10029-012-1006-2. Epub 2012 Oct 27.

PMID:
23104319
3.

Fine-needle aspiration of thyroid tumors: identifying factors associated with adequacy rate in a large academic center in the Netherlands.

de Meer SG, Schreinemakers JM, Zelissen PM, Stapper G, Sie-Go DM, Rinkes IH, Vriens MR.

Diagn Cytopathol. 2012 May;40 Suppl 1:E21-6. doi: 10.1002/dc.21521. Epub 2010 Dec 14.

PMID:
22619155
4.

Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer.

de Meer SG, Dauwan M, de Keizer B, Valk GD, Borel Rinkes IH, Vriens MR.

World J Surg. 2012 Jun;36(6):1262-7. doi: 10.1007/s00268-012-1427-1.

5.

The role of routine diagnostic radioiodine whole-body scintigraphy in patients with high-risk differentiated thyroid cancer.

de Meer SG, Vriens MR, Zelissen PM, Borel Rinkes IH, de Keizer B.

J Nucl Med. 2011 Jan;52(1):56-9. doi: 10.2967/jnumed.110.080697. Epub 2010 Dec 13.

Supplemental Content

Loading ...
Support Center